BMJ editorial slams state's 'abrogation of its duty' over Brexit

29 May 2018
brexit_pills_large-1-

A strongly-worded editorial in the British Medical Journal (BMJ) has called on healthcare professionals to stand up and highlight what it calls the ‘risks of Brexit to our health and our health services’.

The piece is authored by Mike Gill, retired regional director of public health, the academic Martin McKee, campaigner Mark Malloch Brown and Fiona Godlee, editor in chief of the BMJ. All declare that they voted to remain in the European Union (EU) in the 2016 referendum.

"Over and above the direct effects of budget cuts, there are also severe threats to the supply of health workers, access to pharmaceuticals, medical isotopes, health technology, and much else"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical